From 1 January 2021, the Medicines and Healthcare products Regulatory Agency (MHRA) will be the UK’s standalone medicines and medical devices regulator.
This month the UK’s medicines regulator has published two new guidance documents:
Stakeholders need to get ready for new rules.
Asphalion, an International Scientific and Regulatory Affairs Consultancy, offers regulatory solutions in the UK and can ease your path through this transition, assessing you on each step of the way. Contact us at london@asphalion.com
La mejor actitud que podemos adoptar es la de trat...
The research team observed changes in head circumf...
AtCDF3 gene induced greater production of sugars a...
En nuestro post hablamos sobre este interesante tipo de célula del...
The results show that adenocarcinoma exhibits much more active and fun...
Biotechnology portal in Spain
Subscribe to our newsletter and stay up to date with the latest news and deals!
2013 © Biotech-Spain.com - Site Developments SL. All Rights Reserved. Terms of Service | Privacy Policy
Articles
Directory
